Literature DB >> 18281422

Combined newborn screening for succinylacetone, amino acids, and acylcarnitines in dried blood spots.

Coleman Turgeon1, Mark J Magera, Pierre Allard, Silvia Tortorelli, Dimitar Gavrilov, Devin Oglesbee, Kimiyo Raymond, Piero Rinaldo, Dietrich Matern.   

Abstract

BACKGROUND: Tyrosinemia type I (TYR 1) is a disorder causing early death if left untreated. Newborn screening (NBS) for this condition is problematic because determination of the diagnostic marker, succinylacetone (SUAC), requires a separate first-tier or only partially effective second-tier analysis based on tyrosine concentration. To overcome these problems, we developed a new assay that simultaneously determines acylcarnitines (AC), amino acids (AA), and SUAC in dried blood spots (DBS) by flow injection tandem mass spectrometry (MS/MS).
METHODS: We extracted 3/16-inch DBS punches with 300 microL methanol containing AA and AC stable isotope-labeled internal standards. This extract was derivatized with butanol-HCl. In parallel, we extracted SUAC from the residual filter paper with 100 microL of a 15 mmol/L hydrazine solution containing the internal standard 13C5-SUAC. We combined the derivatized aliquots in acetonitrile for MS/MS analysis of AC and AA with additional SRM experiments for SUAC (m/z 155-137) and 13C5-SUAC (m/z 160-142). Analysis time was 1.2 min.
RESULTS: SUAC was increased in retrospectively analyzed NBS samples of 11 TYR 1 patients (length of storage, 52 months to 1 week; SUAC range, 13-81 micromol/L), with Tyr concentrations ranging from 65 to 293 micromol/L in the original NBS analysis. The mean concentration of SUAC in 13 521 control DBS was 1.25 micromol/L.
CONCLUSION: The inclusion of SUAC analysis into routine analysis of AC and AA allows for rapid and cost-effective screening for TYR 1 with no tangible risk of false-negative results.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18281422     DOI: 10.1373/clinchem.2007.101949

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  37 in total

1.  Expanded newborn screening in Greece: 30 months of experience.

Authors:  Yannis L Loukas; Georgios-Stefanos Soumelas; Yannis Dotsikas; Vassiliki Georgiou; Elina Molou; Georgia Thodi; Maria Boutsini; Sofia Biti; Konstantinos Papadopoulos
Journal:  J Inherit Metab Dis       Date:  2010-08-19       Impact factor: 4.982

2.  3-hydroxyacyl-coenzyme a dehydrogenase deficiency: identification of a new mutation causing hyperinsulinemic hypoketotic hypoglycemia, altered organic acids and acylcarnitines concentrations.

Authors:  Florina Ion Popa; Silvia Perlini; Francesca Teofoli; Daniela Degani; Silvia Funghini; Giancarlo La Marca; Piero Rinaldo; Monica Vincenzi; Franco Antoniazzi; Attilio Boner; Marta Camilot
Journal:  JIMD Rep       Date:  2011-09-06

3.  The Proline/Citrulline Ratio as a Biomarker for OAT Deficiency in Early Infancy.

Authors:  Monique G M de Sain-van der Velden; Piero Rinaldo; Bert Elvers; Mick Henderson; John H Walter; Berthil H C M T Prinsen; Nanda M Verhoeven-Duif; Tom J de Koning; Peter van Hasselt
Journal:  JIMD Rep       Date:  2012-02-24

4.  Newborn Screening for Tyrosinemia Type I: Further Evidence that Succinylacetone Determination on Blood Spot Is Essential.

Authors:  Giancarlo la Marca; Sabrina Malvagia; Elisabetta Pasquini; Catia Cavicchi; Amelia Morrone; Federica Ciani; Silvia Funghini; Fabio Villanelli; Enrico Zammarchi; Renzo Guerrini
Journal:  JIMD Rep       Date:  2011-06-22

5.  Efficient production of Fah-null heterozygote pigs by chimeric adeno-associated virus-mediated gene knockout and somatic cell nuclear transfer.

Authors:  Raymond D Hickey; Joseph B Lillegard; James E Fisher; Travis J McKenzie; Sean E Hofherr; Milton J Finegold; Scott L Nyberg; Markus Grompe
Journal:  Hepatology       Date:  2011-08-09       Impact factor: 17.425

6.  Succinylacetone as primary marker to detect tyrosinemia type I in newborns and its measurement by newborn screening programs.

Authors:  Víctor R De Jesús; Barbara W Adam; Daniel Mandel; Carla D Cuthbert; Dietrich Matern
Journal:  Mol Genet Metab       Date:  2014-07-17       Impact factor: 4.797

7.  Neu-Laxova syndrome, an inborn error of serine metabolism, is caused by mutations in PHGDH.

Authors:  Ranad Shaheen; Zuhair Rahbeeni; Amal Alhashem; Eissa Faqeih; Qi Zhao; Yong Xiong; Agaadir Almoisheer; Sarah M Al-Qattan; Halima A Almadani; Noufa Al-Onazi; Badi S Al-Baqawi; Mohammad Ali Saleh; Fowzan S Alkuraya
Journal:  Am J Hum Genet       Date:  2014-05-15       Impact factor: 11.025

8.  Chronic Phenotype Characterization of a Large-Animal Model of Hereditary Tyrosinemia Type 1.

Authors:  Faysal Elgilani; Shennen A Mao; Jaime M Glorioso; Meng Yin; Ianko D Iankov; Anisha Singh; Bruce Amiot; Piero Rinaldo; Ronald J Marler; Richard L Ehman; Markus Grompe; Joseph B Lillegard; Raymond D Hickey; Scott L Nyberg
Journal:  Am J Pathol       Date:  2016-11-14       Impact factor: 4.307

9.  The heritability of metabolic profiles in newborn twins.

Authors:  F Y Alul; D E Cook; O A Shchelochkov; L G Fleener; S L Berberich; J C Murray; K K Ryckman
Journal:  Heredity (Edinb)       Date:  2012-11-14       Impact factor: 3.821

10.  Performance of succinylacetone assays and their associated proficiency testing outcomes.

Authors:  B W Adam; E M Hall; N K Meredith; T H Lim; C A Haynes; V R De Jesus; W H Hannon
Journal:  Clin Biochem       Date:  2012-08-11       Impact factor: 3.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.